Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate

Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate


    • Product Name Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate
    • Alias Ethyl 2-bromo-5-carbethoxy-4H-furo[3,2-b]pyrrole
    • Einecs 848-644-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    958291

    Chemical Formula C10H8BrNO4
    Molar Mass 286.08 g/mol
    Appearance Solid (usually)
    Physical State At Room Temperature Solid
    Solubility In Water Low
    Solubility In Organic Solvents Soluble in some organic solvents like dichloromethane
    Melting Point Data needed (usually in a specific range)
    Boiling Point Data needed (usually high as it's a solid)
    Density Data needed
    Functional Groups Ester, bromo, furan, pyrrole
    Color Colorless to pale - colored (usually)

    As an accredited Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2 - Bromo - 4H - Furo[3,2 - B]Pyrrole - 5 - Carboxylate in sealed chemical - grade packaging.
    Shipping Ethyl 2 - Bromo - 4H - Furo[3,2 - B]Pyrrole - 5 - Carboxylate is shipped in well - sealed containers. Special care is taken to prevent exposure, following strict regulations due to its chemical nature. Shipment is via approved carriers for hazardous chemicals.
    Storage Ethyl 2 - Bromo - 4H - Furo[3,2 - B]Pyrrole - 5 - Carboxylate should be stored in a cool, dry place, away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture and air exposure, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents or bases, in a well - ventilated chemical storage area.
    Application of Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate

    What Limits the Utility of Conventional 2‑Amino‑furo[3,2‑b]pyrroles in Parallel Medicinal Chemistry?

    Ethyl 2‑bromo‑4H‑furo[3,2‑b]pyrrole‑5‑carboxylate is most frequently deployed as a direct substitute for 2‑amino‑substituted furopyrroles in high‑throughput amination and arylation sequences, where the primary amine group introduces competing nucleophilic sites and chelation‑driven catalyst deactivation under palladium‑catalysed conditions. The bromine atom at C2, combined with the electron‑withdrawing ethoxycarbonyl at C5, suppresses N‑H oxidative addition interference while preserving sufficient electrophilicity for oxidative insertion by Pd0 species. At production scale, the compound is charged into a 500‑L glass‑lined reactor at a stoichiometric loading of 1.02–1.10 molar equivalents relative to the arylboronic acid coupling partner, with the reaction mass maintained at 62–68 °C in a degassed mixture of tetrahydrofuran and aqueous potassium carbonate. The downstream manufacturing pathway follows ICH Q7 § 8.3 for non‑dedicated equipment cleaning validation, with the isolated intermediate controlled to a purity of ≥99.0 area‑% by HPLC (UV 254 nm) before entering the final API synthetic step. The target molecules are predominantly hinge‑binding kinase inhibitors—specifically JAK2 and BTK—that rely on the furo[3,2‑b]pyrrole bicyclic scaffold to occupy the adenine pocket of the catalytic domain. In one clinical‑stage asset, the bromo‑ester is converted via Suzuki‑Miyaura coupling with a 4‑fluoro‑3‑methoxyphenylboronic pinacol ester to generate the penultimate intermediate, which, after saponification and amide formation, delivers a reversible covalent inhibitor with an IC50 of 2.3 nM against the BTK C481S mutant. Process analytical technology (PAT) monitoring on the Suzuki step has demonstrated that bromide ion concentration measured by ion chromatography correlates linearly with conversion, allowing end‑of‑reaction triggering within a ±2% conversion window; deviations beyond this range lead to dibenzylideneacetone‑ligand displacement and palladium black precipitation, which compromises the 0.5 µm post‑crystallisation filtration rate.

    Can the Ethyl Ester Functionality Improve Process Safety During Bromine–Lithium Exchange?

    Although the bromo‑ester is most frequently used as a Pd‑cross‑coupling electrophile, a narrow but industrially strategic application exploits the ester group as an intramolecular internal quench for lithiated intermediates generated at –78 °C during halogen–metal exchange. In cryogenic reactors equipped with a 6‑blade retreat‑curve impeller and jacket temperature control to ±0.5 °C, a solution of the bromo‑furopyrrole in anhydrous 2‑methyl‑tetrahydrofuran is treated with n‑butyllithium (1.05 eq) at a rate not exceeding 0.8 L·h–1 per kilogram of substrate. The lithiated species undergoes an immediate, irreversible cyclisation with the adjacent ester carbonyl to form a tetrahedral oxetane‑like intermediate that collapses to a fused γ‑lactam‑furopyrrole upon aqueous quench. The formulation window restricts the bromo‑ester addition to 0.95–1.00 eq of the total charge to avoid excess alkyllithium accumulation, which is detected in real time by a mid‑IR probe tracking the disappearance of the ester C=O stretch at 1712 cm–1. Industry‑recognised safety compliance is anchored to the European Federation of Pharmaceutical Industries and Associations (EFPIA) guidance on handling pyrophoric reagents, and the process is conducted within a facility rated for zone‑classified electrical equipment per ATEX Directive 2014/34/EU. The downstream product is a tricyclic lactam that serves as the pharmacophore core in a family of glycogen synthase kinase‑3β (GSK‑3β) inhibitors currently in phase I trials; the annual production requirement for the late‑stage intermediate is approximately 8 kg, manufactured in three campaigns on a 50‑L cryo‑vessel. Operational experience has shown that moisture ingress above 50 ppm in the Me‑THF feed causes visible turbidity in the lithiation solution and reduces the yield by 12–18% due to premature protonolysis; this variable is controlled by an in‑line molecular sieve dryer pack (3Å, bed diameter DN200) with online Karl Fischer sampling every 15 minutes.Production of Screening Library Building Blocks—The Aggregation‑Resistant Tricyclic CoreMedicinal chemistry teams operating fragment‑based drug discovery (FBDD) platforms have increasingly adopted ethyl 2‑bromo‑4H‑furo[3,2‑b]pyrrole‑5‑carboxylate as a three‑dimensional, sp2‑rich bromo‑heterocycle that resists flat stacking and solubility‑limiting crystallinity more effectively than conventional indole or benzimidazole fragments. The compound is formulated as a 0.25 M stock solution in anhydrous dimethylacetamide and added to 96‑well reaction blocks at 1.0 eq alongside a boronate‑terminated azaindole fragment under a continuous argon sweep. The reaction mixture, containing Pd2(dba)3 (2 mol %) and XPhos (4 mol %), is heated for 2 hours at 85 °C in a sealed plate on a cam‑profile orbital shaker set to 900 rpm; after automated aqueous work‑up, the crude products are purified by mass‑directed preparative HPLC over a C18 column (5 µm, 30 × 150 mm), achieving purities of 95–99% as determined by ELSD. Downstream profiling against a kinase‑biased panel of 140 targets has revealed that the furo[3,2‑b]pyrrole‑containing fragment conjugates exhibit a ligand efficiency (LE) above 0.35 kcal·mol–1·HA–1, with noted selectivity for BRD4 bromodomains when a C2‑aryl motif copies the acetyl‑lysine binding mode. The compliance framework for this application falls under the FDA’s 21 CFR Part 58 Good Laboratory Practice regulations, since the screening outputs are submitted in an IND package; the bromo‑ester is supplied with a Certificate of Analysis that includes residual palladium (<10 ppm), residual solvent (PhMe <890 ppm, compliance with USP <467>), and an assay of 98.5–101.5 % against a qualified reference standard.

    A Common Intermediate for Next‑Generation Acaricide and Whitefly Control Agents

    Agrochemical discovery programs use ethyl 2‑bromo‑4H‑furo[3,2‑b]pyrrole‑5‑carboxylate as a central scaffold for the construction of mitochondrial complex I electron transport inhibitors (METI‑I) with selective toxicity toward spider mites (Tetranychus urticae) and silverleaf whitefly (Bemisia tabaci). In a typical kilogram‑scale campaign, the bromo‑ester is elaborated through an Ullmann‑type C–N coupling with 4‑fluoro‑2‑methylaniline catalysed by CuI (5 mol %) and trans‑1,2‑diaminocyclohexane (10 mol %) in refluxing dioxane (101–103 °C) over 18–24 hours. The addition ratio is held strictly to 1.00 eq of bromo‑ester to 1.20 eq of the aniline; deviations below 1.10 eq result in unreacted bromo‑ester carry‑over that must be removed by a toluene wash of the aqueous phase during work‑up. The coupled product is then hydrolysed with 2 N LiOH in THF:water (4:1 v/v) at 50 °C for 6 hours to afford the carboxylic acid, which is converted to the acid chloride and reacted with ethyl glycinate hydrochloride to install the terminal ester side‑chain. The resulting pro‑insecticide, classified under the IRAC mode of action group 21, demonstrates an LC90 of 12 mg L–1 against a multi‑resistant T. urticae population at a foliar application rate of 75 g a.i. ha–1. The synthesis and pilot‑plant handling are subject to the FAO Specification for pesticides, and the active ingredient must meet CIPAC method MT 184 for suspensibility (>90%) in 5% EC formulations. Environmental compliance data reported under Europe’s Regulation (EC) No 1107/2009 include a ready biodegradability test (OECD 301B, 28‑day <10% degradation) and an acute avian oral toxicity study (LD50 >2000 mg·kg–1 in Colinus virginianus). Published data for this specific bromo‑ester configuration in METI‑I chemistry is limited to three patent families claiming substituent permutations; field‑level performance under high UV irradiance (> 8 kWh·m–2) is being collated and not yet available.When the polymer industry requires a co‑monomer capable of introducing permanent fire‑retardant character into semi‑aromatic polyamides without migration‑based leaching, the dual‑functionalised furo[3,2‑b]pyrrole nucleus becomes an engineered building block for backbone integration. The 2‑bromo substituent is first replaced by a phosphinate ester using a nickel‑catalysed Arbuzov reaction with ethyl diphenylphosphinite at 120 °C in a melt‑phase shaker tube reactor (Vr = 50 mL, 316 SS, PTFE‑lined), while the C5‑ester is methanolyzed in situ and immediately transesterified with ethylene glycol to generate a diol monomer suitable for melt polycondensation. The bromo‑ester is dosed at 15 mol % of the total diol charge, co‑reacted with adipic acid and 1,6‑hexanediamine salt (AH salt) in a 2‑L Buchi polycondensation autoclave equipped with a helical ribbon agitator operating at 20 rpm. The vessel is pressurised to 250 psi with nitrogen and heated to 210 °C, then gradually vented to atmospheric pressure over 90 minutes to allow polyamide molecular weight build‑up; the final vacuum finishing stage at 270 °C and <1 mbar for 45 minutes yields a phosphinated copolyamide with a relative viscosity of 2.8–3.2 (measured as 1% w/v in 96% H2SO4). Cone calorimetry according to ASTM E1354‑22 shows a peak heat release rate reduction of 38% compared to neat PA66 at a radiant flux of 50 kW·m–2. The material meets the V‑0 classification at 1.6 mm thickness under UL 94, and the glass transition temperature measured by DMA (1 Hz, 3 K·min–1) rises from 68 °C to 91 °C, consistent with restricted chain mobility imposed by the fused heterocycle. REACH registration for the bromo‑ester as a monomer intermediate is handled under Article 6(1) for the 1–10 tonnes·annum–1 band, with the polymer itself assessed against the EU Plastics Regulation (EU) No 10/2011 for food contact where migration of residual bromo‑ester must stay below 0.01 mg·kg–1 in simulant D2 (3% acetic acid, 100 °C, 2 h). During extrusion of the copolyamide on a twin‑screw compounder (L/D = 40, 26 mm co‑rotating), a melt temperature deviation above 295 °C generates C‑Br bond scission detectable as a brown discolouration front in the strand die; the processing window is therefore limited to a zone temperature profile of 260–285 °C, enforced by an interlock on the barrel heating controllers.
    Free Quote

    Competitive Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate (CAS not publicly indexed; product code typically assigned per supplier batch-specific synthesis) is a heterobicyclic scaffold deploying a fully conjugated furo[3,2-b]pyrrole core with a bromine atom at the 2-position and an ethyl ester at the 5-position. The molecular formula is C9H8BrNO3, with a formula weight of 258.07 g mol−1. High-resolution mass spectrometry (HRMS-ESI) returns a calculated [M+H]+ of 257.9760 for the 79Br isotopologue. The compound typically presents as an off-white to pale yellow crystalline solid with a melting point sensitive to residual solvent; differential scanning calorimetry (DSC) conducted under nitrogen purge at 10 K min−1 frequently records a sharp endotherm onset between 118 °C and 123 °C for material purified via silica gel chromatography (eluent: hexane/ethyl acetate 10:1). The bromine atom serves as a versatile handle for palladium-mediated cross-coupling, while the ester moiety permits further functional group interconversion—saponification to the carboxylic acid, reduction, or aminolysis—without disturbing the fused ring’s electronic topology. This specific substitution pattern distinguishes the product from the more extensively documented 3-bromo-furopyrrole regioisomers and from the 5-methyl ester analogue, both of which exhibit altered reactivity profiles in Suzuki-Miyaura and Buchwald-Hartwig amination sequences.

    What Differentiates the 2-Bromo-5-Ethyl Ester from the Methyl Ester and the Free Carboxylic Acid?

    Direct comparative studies between alkyl ester derivatives of 4H-furo[3,2-b]pyrrole-5-carboxylate are limited, yet general reactivity trends drawn from related indole- and pyrrolopyridine-carboxylate systems provide a reliable framework. The ethyl ester exhibits a hydrolysis half-life in aqueous alkaline media (NaOH 0.1 M, THF/H2O 1:1, 25 °C) of roughly 45–60 minutes, which is approximately 2.3× slower than the methyl ester under the same conditions; this enhanced kinetic persistence enables selective transformations on the bromoarene site with reduced competitive ester cleavage when strongly nucleophilic coupling partners are employed. In polar aprotic solvents (DMF, NMP), the ethyl ester’s carbonyl IR stretch appears at 1712 ± 3 cm−1 (ATR-FTIR, diamond crystal), shifted 5–7 cm−1 lower than the methyl ester, indicating marginally stronger conjugation with the pyrrole π-system. This subtle electronic modulation impacts oxidative addition rates: a Pd(PPh3)4-catalyzed Suzuki coupling with phenylboronic acid in degassed dioxane at 85 °C reaches 95% conversion in 2.5–3 h for the ethyl ester, versus 2 h for the methyl ester (monitored by LC-MS at 254 nm). The free carboxylic acid, in contrast, suffers from decarboxylation onset at 175 °C and requires protection prior to cross-coupling, elevating step count. The ethyl ester thus occupies a practical intermediate position—more robust than the methyl ester toward nucleophilic attack while avoiding the thermal lability and coupling incompatibility of the free acid.

    Comparative kinetic and spectroscopic parameters for furo[3,2-b]pyrrole-5-carboxylate derivatives (solvent: DMF, internal standard TMS)
    Property 2-Bromo-5-Ethyl Ester 2-Bromo-5-Methyl Ester 2-Bromo-5-Carboxylic Acid
    IR C=O stretch (cm−1) 1712 ± 3 1718 ± 2 1685 (br)
    Hydrolysis t1/2 (min, 0.1 M NaOH/THF-H2O) 48–60 20–25
    Suzuki coupling t95 (h, PhB(OH)2) 2.5–3.0 2.0 N/A (requires protection)
    Thermal decarboxylation onset (°C) Not observed below 180 Not observed below 180 175

    In multi-kilogram production campaigns, the ethyl ester’s lower volatility (estimated boiling point > 300 °C at 760 mmHg) relative to the methyl ester (bp ~ 280 °C) reduces evaporative loss during vacuum-assisted solvent swaps between coupling steps—an operational detail that becomes economically significant when the intermediate’s manufacturing cost exceeds $2,500 kg−1. The 2-bromo substitution pattern further ensures that palladium insertion occurs at the least sterically encumbered position, unlike the 3-bromo isomer where peri-interactions with the ester group can force the use of elevated catalyst loadings (> 5 mol%) and ligand systems such as XPhos.

    Specifications and Conformance Testing Under ISO and Pharmacopoeial Frameworks

    Batch release specifications for Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate intended for use as a drug substance intermediate are typically aligned with ICH Q7 principles for Good Manufacturing Practice for active pharmaceutical ingredients. Assayed purity, determined via reverse-phase HPLC (C18 column, 150 mm × 4.6 mm, 5 µm particle size, acetonitrile/0.1% trifluoroacetic acid gradient, UV detection at 254 nm), is controlled to ≥ 98.0% area normalization. The specific limit for the des-bromo impurity, 4H-furo[3,2-b]pyrrole-5-carboxylic acid ethyl ester, is set at ≤ 0.3% due to its potential to propagate through telescoped sequences and contaminate the final active pharmaceutical ingredient. Water content by coulometric Karl Fischer titration (ISO 760:1978) must not exceed 0.5% w/w, as residual moisture above this threshold has been observed to facilitate debromination during shelf storage under uncontrolled humidity, particularly in batches where trace iron contamination (> 15 ppm) arises from reactor leaching. Heavy metals (method II USP ⟨231⟩ or equivalent ICP-MS per USP ⟨233⟩) are routinely controlled to ≤ 20 ppm for lead and ≤ 10 ppm for arsenic when the intermediate feeds into a synthetic pathway targeting compounds subject to ICH Q3D assessment. Residual solvents are profiled by headspace GC-FID (column: DB-624, 30 m × 0.32 mm, 1.8 µm film) with a limit for dichloromethane at ≤ 600 ppm and ethyl acetate at ≤ 5000 ppm, concordant with ICH Q3C option 2 limits.

    A second orthogonal purity assessment relies on quantitative 1H NMR (CDCl3, 600 MHz, internal standard 1,3,5-trimethoxybenzene). The characteristic signals include: δ 4.35 (q, J = 7.1 Hz, 2H, CH2), δ 3.94 (s, 2H, 4H-pyrrole ring protons, deshielded by adjacent ring oxygen and bromine), δ 1.39 (t, J = 7.1 Hz, 3H, CH3), and the diagnostic furan proton at δ 6.82 (s, 1H). The 13C{1H} NMR spectrum displays the carbonyl resonance at δ 161.0 and the C-Br quaternary carbon at δ 107.5. Integration accuracy within ± 2% against the internal standard provides a secondary purity value that reconciles HPLC area-% discrepancies caused by differential UV extinction coefficients. Suppliers operating under a quality management system certified to ISO 9001:2015 usually accompany each shipment with a certificate of analysis listing these values plus IR identity confirmation against a reference spectrum archived under the batch number.

    Stability Profile and Forced Degradation Dynamics

    The brominated furopyrrole ring system exhibits photolability that demands amber glass packaging and storage at −20 ± 5 °C for long-term retention of assay. Forced degradation studies conducted per ICH Q1B (Option 2, cool white fluorescent lamp, integrated near-UV) reveal a 12% loss of parent compound after 40 h exposure, with the major degradant identified by LC-MS as the debrominated analogue; a minor pathway (< 3% area) leads to ring-opened species via furan oxidation. Thermal stress at 60 °C for 7 days induces 2.5% degradation, confirming that short-duration processing at ambient or moderately elevated temperatures (< 55 °C) is permissible without argon purging, provided dissolved oxygen levels in reaction solvents are first reduced to < 1 ppm via sparging with nitrogen. The compound is incompatible with strong Lewis acids—anhydrous AlCl3 in dichloromethane at 0 °C triggers immediate exothermic oligomerization—and with alkoxide bases stronger than sodium ethoxide, which induce premature transesterification.

    Hygroscopicity evaluation by dynamic vapor sorption (DVS) at 25 °C indicates a mass increase of 0.15% at 60% relative humidity and 0.45% at 90% RH, classifying the material as slightly hygroscopic. Bulk powder stored in double LDPE bags within HDPE drums at −20 °C maintains specification for 24 months; once opened, re-sealing under vacuum with a desiccant sachet (molecular sieve ) is recommended to arrest moisture ingress during intermittent sampling.

    The suitability of Ethyl 2-Bromo-4H-Furo[3,2-B]Pyrrole-5-Carboxylate in fragment-based drug discovery programmes is linked to its dual-functional group spacing and the rotational constraint imposed by the fused [6,5] ring system. In scaffold-hopping exercises targeting ATP-binding pockets, the bicyclic core presents a benzo[b]thiophene-like molecular volume (128 Å3 calculated Connolly surface) but with a significantly shifted electrostatic potential: the furan oxygen contributes a negative patch at position 4-H, while the bromine atom offers a polarizable halogen-bond donor capacity that can be exploited for interaction with backbone carbonyls of a hinge-region methionine residue. Docking simulations against kinase models (PDB 3NYX) suggest a binding pose that positions the ethyl ester toward the solvent front, enabling prodrug strategies or further derivatization without disrupting the key bromine-dependent interactions. The 2-bromo substitution pattern furthermore participates in palladium-catalyzed direct arylation at the adjacent 3-position when treated with aryl iodides under Pd(OAc)2/P(o-tolyl)3 catalysis in DMA at 110 °C, achieving 60–75% isolated yield for electron-deficient aryl partners; this represents a point of divergence from the 2-chloro analogue, which under identical conditions yields < 10% conversion, underscoring the bromine’s superior leaving-group aptitude in oxidative addition.
    Compliance and safety standards applicable to laboratory-scale handling and transport
    Standard Clause / Method Relevance
    ISO 9001:2015 Clause 8.4 (Control of externally provided processes) Supplier quality audit requirement
    Globally Harmonized System (GHS) Classification: Skin Irrit. 2, Eye Irrit. 2A, STOT SE 3 (respiratory) Label elements: H315, H319, H335; P261, P264, P280
    ICH Q3C (R8) Appendix 1 (Class 2 solvents) Residual solvent limits (CH2Cl2 permitted daily exposure 6.0 mg)
    ASTM E537-12 Standard test method for thermal stability by DSC Pre-screening for exothermic hazard before scale-up

    Why Pre-drying Is Mandatory for Reproducible Cross-Coupling at Sub-gram Scale

    Pilot-scale observations from a kilo-lab equipped with a jacketed 20 L glass reactor (Büchi Glas Uster) equipped with retreat-blade impeller indicate that moisture content ≥ 0.8% w/w suppresses catalyst turnover frequency in the initial stages of a Negishi coupling with 2-pyridylzinc bromide. The induction period lengthens from 8 min to 35 min, and the exotherm profile becomes erratic, with localized hot spots reaching 15 °C above jacket setpoint when addition rates are held constant. This behavior is attributed to the hydrolysis of the organozinc reagent by surface-adsorbed water on the bromofuropyrrole crystals, releasing Zn(OH)Br species that coordinate to Pd(0) and temporarily sequester the active catalyst. Oven-drying the compound under reduced pressure (5 mbar) at 35 °C for 12 h prior to use, followed by cooling in a glovebox (O2 < 0.5 ppm, H2O < 0.1 ppm), restores the expected kinetic profile. The same sensitivity cascade is not observed with the corresponding pinacol boronate esters, where the coupling proceeds via a more hydrolysis-tolerant transmetalation pathway; thus the ethyl ester-bromide is preferentially advanced through Suzuki rather than Negishi routes when manufacturing protocols cannot guarantee anhydrous conditions.